www.ethypharm.com Open in urlscan Pro
91.212.205.200  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Close


WARNING

You are about to leave ethypharm.com

Regulations vary by country. The information provided on the website you wish to
visit may not correspond to that of your country.

Click on CONTINUE if you wish to access the site of one of our subsidiaries.

Continue
 * Newsroom
 * Contact
 * Groupe websites
   * China
   * France
   * Germany
   * United Kingdom
   * Altan Pharmaceuticals
   * Ethypharm Digital Therapy

 * About us
   About us
   
    * At a glance
    * Management Team
    * Responsibility
    * Footprint
    * History

 * Our specialties
   Our specialties
   
    * CNS
    * Hospital Injectables

 * Development
   Development
   
    * R&D
    * Business development

 * Join us


 * Contact
 * Group websites
   Group websites
   
    * Altan Pharmaceuticals
    * Ethypharm Digital Therapy

Newsroom



ETHYPHARM – BEYOND OUR MEDICINES, LIVES



Ethypharm is a specialty pharmaceutical company with European roots, focused on
specific Central Nervous System (CNS) diseases and conditions, and on Hospital
Injectables.

  Discover Ethypharm at a glance


A COMMITMENT TO THE PATIENTS WE SERVE

Many of our products are indicated for sensitive situations in which patients
either suffer from debilitating conditions such as chronic pain or addiction, or
are in a critical state.
All around the world, Ethypharm employees are engaged daily to make the
difference for patients’ lives by ensuring they are able to receive the right
treatment at the right time and with the right support.

Read more on our commitments


ADDING VALUE IN CNS AND HOSPITAL INJECTABLES

Ethypharm is deeply engaged in the CNS and Hospital Injectable areas, where our
medicines treat patients today and our teams work on innovative solutions for
tomorrow. Willing to grow beyond our recognised positions in the treatment of
severe pain and opioid dependency, we are constantly screening opportunities in
search for those which will respond to unmet needs in our two core areas.

CNS at Ethypharm Hospital Injectables at Ethypharm


A GROUP ON A DYNAMIC DEVELOPMENT JOURNEY

Ethypharm is a rapidly transforming company, with a clear strategy and
significant growth ambition. Our teams are constantly looking for opportunities
to develop our product portfolio, selectively enlarge our geographical coverage
and enrich our development pipeline. We are extremely open to discussing
potential partnerships. Get to know our R&D and business development (BD) teams
and come discuss with us!

R&D at Ethypharm BD at Ethypharm




ETHYPHARM'S LATEST NEWS

Ethypharm Digital Therapy announces the launch of its website

On December 17th, 2021 – Ethypharm Digital Therapy (EDT) announces a new step on
its development path with the launch of its website.
This new window on digital therapies (DTx) will allow EDT to inform a wide
audience about the health benefits of DTx.

Click here to discover the new website
NB: By clicking on this link, you will be redirected to an external website

 

 

Ethypharm is the first European pharmaceutical laboratory to be awarded the
LUCIE 26000 label for its CSR commitment.

On December 16, 2021 – Ethypharm announces that it has obtained the LUCIE 26000
label and joins Europe’s leading committed and responsible community. A first
for a pharmaceutical company. This certification initially concerns Ethypharm’s
main European subsidiaries: United Kingdom, France and Germany.
This certification reflects Ethypharm’s commitment to a CSR approach that is
fully integrated into its development and respects all its stakeholders.

Read the full press release in our newsroom
NB: By clicking on this link, you will be redirected to an external website

Ethypharm is growing fast and is always looking to enrich its teams with new
talented individuals. We encourage you to visit this site regularly and to
follow Ethypharm on LinkedIn to read our latest updates and stay informed about
our job opportunities.


Linked
Join us Contact
 * © Ethypharm 2023
    * Legal notice
    * Data protection policy
    * Site map



Close
Cookies management panel
By allowing these third party services, you accept their cookies and the use of
tracking technologies necessary for their proper functioning.

For more information, please read our Data protection policy.
Preference for all services
✓ Allow all cookies ✗ Deny all cookies
 *   Mandatory cookies
   * This site uses cookies necessary for its proper functioning which cannot be
     deactivated.
     
     ✓ Allow ✗ Deny
 * ✛ APIs
   APIs are used to load scripts: geolocation, search engines, translations, ...
 * ✛ Advertising network
   Ad networks can generate revenue by selling advertising space on the site.
 * ✛ Audience measurement
   The audience measurement services used to generate useful statistics
   attendance to improve the site.
   * Google Analytics (gtag.js) This service can install 9 cookies.
     Read more - View the official website
     ✓ Allow ✗ Deny
 * ✛ Comments
   Comments managers facilitate the filing of comments and fight against spam.
 * ✛ Other
   Services to display web content.
 * ✛ Social networks
   Social networks can improve the usability of the site and help to promote it
   via the shares.
 * ✛ Support
   Support services allow you to get in touch with the site team and help to
   improve it.
 * ✛ Videos
   Video sharing services help to add rich media on the site and increase its
   visibility.
 * This website does not use any cookie requiring your consent.


This website uses cookies to improve your experience and understand how visitors
of our site use it. ✓ Accept all Personalize For more information, please read
our Data protection policy.